Thomas Elmer Witzig, MD

  • 38902 Citations
  • 107 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Thomas Elmer Witzig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 48 Similar Profiles
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Radioimmunotherapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2017

Phosphatidylinositol 3-Kinase
Signal Transduction
Lymphoma
Non-Hodgkin's Lymphoma
raf Kinases
Mantle-Cell Lymphoma
Inositol
Phosphotransferases
Sirolimus
Neoplasms

Lymphoma Specialized Program of Research Excellence

Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R., Smith, B. J., Kaufmann, S. H., Feldman, A. L. & Witzig, T. E.

National Institutes of Health

9/11/026/30/17

Project: Research project

Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma
Radioimmunotherapy
Lymphoma
Non-Hodgkin's Lymphoma
Bone Marrow
Anti-Idiotypic Antibodies
Colonic Neoplasms
Apoptosis
Cell Proliferation
Neoplasms
Growth

Research Output 1985 2019

Acalabrutinib for mantle cell lymphoma

Witzig, T. E. & Inwards, D., Jan 1 2019, In : Blood. 133, 24, p. 2570-2574 5 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cyclin D1
United States Food and Drug Administration
Non-Hodgkin's Lymphoma
Clinical Trials
1 Citation (Scopus)

Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma

Shenoy, N., Bhagat, T. D., Cheville, J., Lohse, C., Bhattacharyya, S., Tischer, A., Machha, V., Gordon-Mitchell, S., Choudhary, G., Wong, L. F., Gross, L. A., Ressigue, E., Leibovich, B., Boorjian, S. A., Steidl, U., Wu, X., Pradhan, K., Gartrell, B., Agarwal, B., Pagliaro, L. & 8 others, Suzuki, M., Greally, J. M., Rakheja, D., Houston Thompson, R., Susztak, K., Witzig, T. E., Zou, Y. & Verma, A., Apr 1 2019, In : Journal of Clinical Investigation. 129, 4, p. 1612-1625 14 p.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Ascorbic Acid
Methylation
Cytosine
Protein Transport

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

Sahin, I., Kawano, Y., Sklavenitis-Pistofidis, R., Moschetta, M., Mishima, Y., Manier, S., Sacco, A., Carrasco, R., Fonseca, R., Roccaro, A. M., Witzig, T. E. & Ghobrial, I. M., Apr 9 2019, In : Blood Advances. 3, 7, p. 995-1002 8 p.

Research output: Contribution to journalArticle

Open Access
Cytokinesis
Multiple Myeloma
Growth
Neoplasms
Protein-Serine-Threonine Kinases
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha